Iveric Bio
Kelly Parrott Weaver is an accomplished professional in the healthcare and pharmaceutical sectors with extensive experience in access and reimbursement management, particularly within ophthalmology and specialty markets. Currently serving as an Access Reimbursement Manager at Iveric Bio, Kelly has previously held strategic roles at Biogen, where responsibilities included managing reimbursement and access for biosimilars in the retina market, as well as developing strategies for Alzheimer's products. Additional experience encompasses positions at United Therapeutics Corporation, AstraZeneca, Phonak, The TOVA Company, Jazz Pharmaceuticals, and Johnson & Johnson, with a focus on market access, sales, and business development. Kelly holds a Bachelor of Arts degree in Psychology from the University of Minnesota Duluth, earned in 1992.
This person is not in the org chart
This person is not in any offices
Iveric Bio
Iveric Bio is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs.